Lyra Therapeutics Inc

NASDAQ:LYRA  
7.88
+0.03 (+0.38%)
Earnings Announcements

Lyra Reports Q4 Results, Provides Corporate Update

Published: 03/09/2021 22:47 GMT
Lyra Therapeutics Inc (LYRA) - Lyra Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results, Provides Corporate Update.
Lyra Therapeutics Inc - Believe Co Has Sufficient Cash to Fund Co Through Planned Operations Into 2023.
Revenue is expected to be $0.38 Million
Adjusted EPS is expected to be -$0.74

Next Quarter Revenue Guidance is expected to be $0.63 Million
Next Quarter EPS Guidance is expected to be -$0.83

More details on our Analysts Page.